SMTL ID : 4id7.1

ACK1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

homo-dimer

Ligands

2 x 1G0: cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol(Non-covalent)

1G0.1: 17 residues within 4Å: Chain A: L.16, V.24, A.40, K.42, E.61, M.65, I.74, L.76, M.87, T.89, E.90, L.91, A.92, S.96, L.143, G.153, F.155 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:M.65, A:I.74, A:L.76, A:L.76, A:F.155 Hydrogen bonds: A:T.89, A:E.90, A:A.92 1G0.3: 17 residues within 4Å: Chain B: L.16, V.24, A.40, K.42, E.61, M.65, I.74, L.76, M.87, T.89, E.90, L.91, A.92, S.96, L.143, G.153, F.155 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:M.65, B:I.74, B:L.76, B:L.76, B:F.155 Hydrogen bonds: B:T.89, B:E.90, B:A.92

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 7 residues within 4Å: Chain A: R.135, R.159, Y.168, V.169, M.170, Q.171, R.174 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Y.168, A:V.169, A:Q.171 Salt bridges: A:R.135, A:R.159, A:R.174 SO4.4: 7 residues within 4Å: Chain B: R.135, R.159, Y.168, V.169, M.170, Q.171, R.174 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:V.169, B:Q.171 Salt bridges: B:R.135, B:R.159, B:R.174

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jin, M. et al., Discovery of potent, selective and orally bioavailable imidazo[1,5-a]pyrazine derived ACK1 inhibitors. Bioorg.Med.Chem.Lett. (2013)

Release Date

2013-01-30

Peptides

Activated CDC42 kinase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Activated CDC42 kinase 1

Related Entries With Identical Sequence